Hyman Niznik - Publications

Affiliations: 
University of Toronto, Toronto, ON, Canada 

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2005 Verma V, Mann A, Costain W, Pontoriero G, Castellano JM, Skoblenick K, Gupta SK, Pristupa Z, Niznik HB, Johnson RL, Nair VD, Mishra RK. Modulation of agonist binding to human dopamine receptor subtypes by L-prolyl-L-leucyl-glycinamide and a peptidomimetic analog. The Journal of Pharmacology and Experimental Therapeutics. 315: 1228-36. PMID 16126839 DOI: 10.1124/Jpet.105.091256  0.547
2004 Jiang C, Wan X, Jankovic J, Christian ST, Pristupa ZB, Niznik HB, Sundsmo JS, Le W. Dopaminergic properties and experimental anti-parkinsonian effects of IPX750 in rodent models of Parkinson disease. Clinical Neuropharmacology. 27: 63-73. PMID 15252266 DOI: 10.1097/00002826-200403000-00004  0.304
2004 Le Crom S, Sugamori KS, Sidhu A, Niznik HB, Vernier P. Delineation of the conserved functional properties of D1A, D1B and D1C dopamine receptor subtypes in vertebrates. Biology of the Cell / Under the Auspices of the European Cell Biology Organization. 96: 383-94. PMID 15207908 DOI: 10.1016/J.Biolcel.2004.03.002  0.556
2002 Lee FJ, Xue S, Pei L, Vukusic B, Chéry N, Wang Y, Wang YT, Niznik HB, Yu XM, Liu F. Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell. 111: 219-30. PMID 12408866 DOI: 10.1016/S0092-8674(02)00962-5  0.477
Show low-probability matches.